Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer

View source ↗

Summary

A clinical trial update indicates recruitment for a study using ctDNA monitoring to predict the efficacy of Total Neoadjuvant Therapy in rectal cancer (stages I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gene Solutions | Conditions: Rectal Cancer, Rectal Cancer Stage II | Status: RECRUITING